Skip to main content

Advertisement

SpringerLink
Log in

Preventive effect of pre-warming, hot compress, and pH adjustment in oxaliplatin-induced venous pain

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background Venous pain induced by peripheral intravenous administration of oxaliplatin remains clinically unresolved. Objective The aim of this study was to determine the efficacy of comprehensive intervention care for venous pain in colorectal cancer patients receiving oxaliplatin. Setting A Japanese tertiary hospital. Method We treated all outpatients after April 2012 with comprehensive intervention care including pre-warming of the oxaliplatin solution, use of a hot compress, and pH adjustment by combination with dexamethasone. We retrospectively reviewed the electronic medical records from colorectal cancer patients who had received oxaliplatin via a peripheral vein between December 2009 and June 2014. Main outcome measures The primary endpoint of this study was the incidence of venous pain at the administration site during oxaliplatin infusion, according to injection site reaction grade ≥ 2. Results We evaluated 271 treatment courses in 59 patients. Venous pain occurred in 42 courses (15.5%) among 26 patients. Multivariate logistic regression analysis revealed that female gender and body mass index ≥ 25 kg/m2 were significantly associated with an increased risk of venous pain during all courses (adjusted odds ratio [OR]: 3.18, 95% confidence interval [CI] 1.35–7.92; P < 0.01; and adjusted OR: 3.37, 95% CI 1.26–9.40; P = 0.02, respectively), whereas comprehensive intervention care were significantly associated with reduced risk of venous pain during all courses (adjusted OR: 0.10, 95% CI 0.02–0.44; P < 0.01). Conclusion Comprehensive intervention care is a clinical treatment option for oxaliplatin-induced peripheral venous pain in patients with colorectal cancer, especially females with obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18:2938–47.

    Article  PubMed  Google Scholar 

  2. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 2004;22:23–30.

    Article  CAS  PubMed  Google Scholar 

  3. Cassidy J, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, et al. Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. J Clin Oncol. 2008;26:2006–12.

    Article  CAS  PubMed  Google Scholar 

  4. Saltz LB, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol. 2008;26:2013–9.

    Article  CAS  PubMed  Google Scholar 

  5. Haller DG, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol. 2011;29:1465–71.

    Article  CAS  PubMed  Google Scholar 

  6. Yamada Y, Takahari D, Matsumoto H, Baba H, Nakamura M, Yoshida K, et al. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial. Lancet Oncol. 2013;14:1278–86.

    Article  CAS  PubMed  Google Scholar 

  7. Yoshida Y, Hoshino S, Aisu N, Naito M, Tanimura S, Mogi A, et al. Administration of chemotherapy via the median cubital vein without implantable central venous access ports: port-free chemotherapy for metastatic colorectal cancer patients. Int J Clin Oncol. 2015;20:332–7.

    Article  CAS  PubMed  Google Scholar 

  8. Matsuyama K, Mishima H, Ueno H, Kajihara K, Morioka A, Morimoto S, et al. Etiology and management of venous pain during intravenous administration of oxaliplatin. Gan To Kagaku Ryoho. 2011;38:411–4 (in Japanese).

    PubMed  Google Scholar 

  9. Yoshida Y, Hoshino S, Aisu N, Shiwaku H, Beppu R, Tanimura S, et al. Dexamethasone as a means not only for controlling vascular pain caused by the administration of oxaliplatin via the peripheral vein but also for controlling oxaliplatin-induced hypersensitivity reactions. Br J Med Med Res. 2012;2:132–41.

    Article  Google Scholar 

  10. Miyajima R, Kawazoe H, Tsuneoka K, Fujiwara M, Kojima Y, Yakushijin Y. Preventive trial of preheating administration of oxaliplatin-diluted solution in combination with a hot compress for oxaliplatin-induced venous pain. Gan To Kagaku Ryoho. 2013;40:537–40 (in Japanese).

    PubMed  Google Scholar 

  11. Nakauchi K, Kawazoe H, Miyajima R, Waizumi C, Rokkaku Y, Tsuneoka K, et al. Risk factors for oxaliplatin-induced phlebitis and venous pain, and evaluation of the preventive effect of preheating with a hot compress for administration of oxaliplatin. Gan To Kagaku Ryoho. 2015;42:1397–400 (in Japanese).

    PubMed  Google Scholar 

  12. Hata T, Honda M, Kobayashi M, Toyokawa A, Tsuda M, Tokunaga Y, et al. Effect of pH adjustment by mixing steroid for venous pain in colorectal cancer patients receiving oxaliplatin through peripheral vein: a multicenter randomized phase II study (APOLLO). Cancer Chemother Pharmacol. 2015;76:1209–15.

    Article  CAS  PubMed  Google Scholar 

  13. Common Terminology Criteria for Adverse Events (Internet). http://evs.nci.nih.gov/ftp1/CTCAE/About.html. Accessed 27 May 2016.

  14. Elias D, Bonnay M, Puizillou JM, Antoun S, Demirdjian S, El OA, et al. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol. 2002;13:267–72.

    Article  CAS  PubMed  Google Scholar 

  15. Royal College of Nursing. Standards for infusion therapy, the RCN IV therapy forum. 3rd ed. London: The Royal College of Nursing; 2010. p. 26–7.

  16. Suga Y, Sakaguchi Y, Ishizaki J, Takabayashi M, Hashimoto C, Hiromasa A, et al. Investigation for risk factor and preventive effect of NSAIDs, opioid on gemcitabine-induced vascular pain. Jpn J Pharm Heath Care Sci. 2012;38:177–83 (in Japanese).

    Article  CAS  Google Scholar 

  17. Yoh K, Niho S, Goto K, Ohmatsu H, Kubota K, Kakinuma R, et al. High body mass index correlates with increased risk of venous irritation by vinorelbine infusion. Jpn J Clin Oncol. 2004;34:206–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all patients and medical staff at Ehime University Hospital who were involved in this study.

Funding

The authors have no financial support or financial conflicts.

Author information

Authors and Affiliations

  1. Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan

    Hitoshi Kawazoe, Satomi Sumikawa, Akihiro Tanaka & Hiroaki Araki

  2. Division of Nursing, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan

    Kana Nakauchi

  3. Cancer Center, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan

    Yoshihiro Yakushijin

  4. Division of Gastrointestinal Surgery and Surgical Oncology, Department of Surgery, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, Japan

    Yuji Yamamoto & Yuji Watanabe

Authors
  1. Hitoshi Kawazoe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Satomi Sumikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kana Nakauchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshihiro Yakushijin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuji Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuji Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Akihiro Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hiroaki Araki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hitoshi Kawazoe.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kawazoe, H., Sumikawa, S., Nakauchi, K. et al. Preventive effect of pre-warming, hot compress, and pH adjustment in oxaliplatin-induced venous pain. Int J Clin Pharm 39, 1291–1297 (2017). https://doi.org/10.1007/s11096-017-0536-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-017-0536-1

Keywords

Search

Navigation